Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Progyny Raises FY2025 Adj EPS Guidance from $1.70-$1.78 to $1.79-$1.82 vs $0.62 Est; Raises FY2025 Sales Guidance from $1.235B-$1.270B to $1.263B-$1.278B vs $1.259B Est

Author: Benzinga Newsdesk | November 06, 2025 04:16pm

Full Year 2025 Outlook:
- Revenue is now projected to be $1.263 billion to $1.278 billion, reflecting growth of 8.2% to 9.5%; excluding the $48.5 million and $136.1 million of revenue in 2025 and 2024, respectively, from the large client who was under a transition agreement in the first half of 2025, revenue is expected to increase by 17.8% to 19.2%
- Net income is projected to be $58.5 million to $61.5 million, or $0.65 to $0.68 per diluted share, on the basis of approximately 90 million assumed weighted-average fully diluted-shares outstanding
- Adjusted EBITDA1 is projected to be $216.0 million to $220.0 million
- Adjusted earnings per diluted share1 is projected to be $1.79 to $1.82

Posted In: PGNY